![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 15, 2020 12:14:31 AM
Congrats on your prior biotech win but, at this point, I am inclined to believe the posted shareholder letter.
The letter said the custodian was to approve a 1 for 1000 reverse split and, despite numerous protestations to the contrary on this board, that's exactly what happened.
The next line in the letter is to approve the creation of a class of Series A convertible preferred shares, each share to convert 1 preferred to 1000 common shares. Depending upon how many shares he decided to issue, those alone could cause significant dilution to common shareholders.
What do you think is going to be the par value of those convertible preferreds?
Remember, the float is around 290,000 now but the authorized shares remain at 1.125 billion.
This leaves massive room for dilution with little protection or control for the common shareholder.
Caveat emptor.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM